1. Home
  2. GBIO vs TWIN Comparison

GBIO vs TWIN Comparison

Compare GBIO & TWIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • TWIN
  • Stock Information
  • Founded
  • GBIO 2016
  • TWIN 1918
  • Country
  • GBIO United States
  • TWIN United States
  • Employees
  • GBIO N/A
  • TWIN N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • TWIN Industrial Machinery/Components
  • Sector
  • GBIO Health Care
  • TWIN Industrials
  • Exchange
  • GBIO Nasdaq
  • TWIN Nasdaq
  • Market Cap
  • GBIO 29.5M
  • TWIN 186.2M
  • IPO Year
  • GBIO 2020
  • TWIN N/A
  • Fundamental
  • Price
  • GBIO $5.86
  • TWIN $13.27
  • Analyst Decision
  • GBIO Buy
  • TWIN Strong Buy
  • Analyst Count
  • GBIO 4
  • TWIN 1
  • Target Price
  • GBIO $10.67
  • TWIN $12.00
  • AVG Volume (30 Days)
  • GBIO 76.7K
  • TWIN 63.1K
  • Earning Date
  • GBIO 11-05-2025
  • TWIN 11-05-2025
  • Dividend Yield
  • GBIO N/A
  • TWIN 1.19%
  • EPS Growth
  • GBIO N/A
  • TWIN N/A
  • EPS
  • GBIO N/A
  • TWIN N/A
  • Revenue
  • GBIO $21,230,000.00
  • TWIN $340,738,000.00
  • Revenue This Year
  • GBIO N/A
  • TWIN $10.79
  • Revenue Next Year
  • GBIO N/A
  • TWIN $8.43
  • P/E Ratio
  • GBIO N/A
  • TWIN N/A
  • Revenue Growth
  • GBIO 61.15
  • TWIN 15.46
  • 52 Week Low
  • GBIO $3.00
  • TWIN $6.16
  • 52 Week High
  • GBIO $29.10
  • TWIN $13.80
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 52.18
  • TWIN 68.29
  • Support Level
  • GBIO $5.51
  • TWIN $13.02
  • Resistance Level
  • GBIO $6.04
  • TWIN $13.77
  • Average True Range (ATR)
  • GBIO 0.31
  • TWIN 0.58
  • MACD
  • GBIO -0.09
  • TWIN -0.08
  • Stochastic Oscillator
  • GBIO 47.30
  • TWIN 70.56

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About TWIN Twin Disc Incorporated

Twin Disc Inc is a United States-based firm engaged in the manufacture and sale of marine and heavy-duty off-highway power transmission equipment. The company operates its business through two reportable segments: Manufacturing and Distribution. Its product portfolio includes marine transmissions, surface drives, propellers, and boat management systems as well as power-shift transmissions, hydraulic torque converters, power take-offs, industrial clutches, and control systems.

Share on Social Networks: